We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ICER: Biogen Alzheimer’s Drug Cost-Effective at $3,000 to $8,400
ICER: Biogen Alzheimer’s Drug Cost-Effective at $3,000 to $8,400
The Institute for Clinical and Economic Review (ICER) has revised upward what it thinks Biogen’s controversial Alzheimer’s disease treatment Aduhelm (aducanumab) ought to cost, but the new estimate is still only a fraction of the $56,000 a year the company proposes to charge.